NCT03306199View on ClinicalTrials.gov

TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

October 3, 2017

Primary Completion Date

June 5, 2018

Study Completion Date

June 5, 2018

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

Laser Atherectomy

The Turbo-Power is a laser atherectomy catheter designed for treatment of de novo or restenotic lesions in native infrainguinal arteries and for the treatment of femoropopliteal artery in-stent restenosis (ISR) in bare nitinol stents with adjunctive percutaneous transluminal angioplasty (PTA).

Trial Locations (1)

70360

Cardiovascular Institute of the South, Houma

All Listed Sponsors
lead

Spectranetics Corporation

INDUSTRY

NCT03306199 - TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions | Biotech Hunter | Biotech Hunter